Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
LY3372689 can be used for tauopathies research
GSK1016790A is a potent and selective transient receptor potential vanilloid 4 (TRPV4) channel agonist
and 3) Amylin (8-37) elicits a significant alteration of in vivo lipid metabolism
Inhibitory effects of curcumenol on human liver cytochrome P450 enzymes
15-pentaoxaoctadecanoic acid
(-)-Cevimeline hydrochloride hemihydrate Catalog No.:M34745-C LY3372689 can be used for( ) Cevimeline hydrochloride hemihydrate (( ) SNI 2011), a novel muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren's syndrome. IC50 value: Target: mAChR The general pharmacol. properties of this drug on the gastrointestinal, urinary, and reproductive systems and other tissues were investigated in mice, rats, guinea pigs, rabbits, and dogs. The in vitro metab. of SNI 2011 was also evaluated with rat and dog liver
US$ 29.00
US$ 138.28
US$ 98.07
US$ 189.56
US$ 113.16
US$ 22.38
US$ 158.00
US$ 40.00